A computational profiling of changes in gene expression and transcription factors induced by vflip k13 in primary effusion lymphoma

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Punj, Vasu ^a,b   Matta, Hittu ^a   Chaudhary, Preet M ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD19 ANTIGEN; CYSTEINE PROTEINASE INHIBITOR; CYTOKINE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; NUCLEAR FACTOR KAPPA B2; RANTES; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR RELB; UNCLASSIFIED DRUG; VIRAL FLICE INHIBITORY PROTEIN K13; CCL5 PROTEIN, HUMAN; LUCIFERASE; VIRAL FLIP PROTEIN, HUMAN HERPESVIRUS 8; VIRUS PROTEIN;

ARTICLE; CANCER CELL CULTURE; CELL ADHESION; CELL DEATH; CHEMOKINE GENE; CLINICAL FEATURE; DOWN REGULATION; GENE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN HERPESVIRUS 8; IMMUNE RESPONSE; IMMUNOPHENOTYPING; INFLAMMATION; MICROARRAY ANALYSIS; MICROVASCULAR ENDOTHELIAL CELL; NUCLEOTIDE SEQUENCE; PRIMARY EFFUSION LYMPHOMA; PROMOTER REGION; PROTEIN ANALYSIS; PROTEIN INDUCTION; SIGNAL TRANSDUCTION; TRANSCRIPTION REGULATION; UNINDEXED SEQUENCE; UPREGULATION; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENETICS; HERPES VIRUS INFECTION; METABOLISM; PHYSIOLOGY; REAL TIME POLYMERASE CHAIN REACTION; TUMOR CELL LINE; VIROLOGY;

HUMAN HERPESVIRUS 8;

CELL LINE, TUMOR; CHEMOKINE CCL5; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HERPESVIRIDAE INFECTIONS; HERPESVIRUS 8, HUMAN; HUMANS; LUCIFERASES; LYMPHOMA, PRIMARY EFFUSION; MICROARRAY ANALYSIS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; REAL-TIME POLYMERASE CHAIN REACTION; VIRAL PROTEINS;

EID: 84862077555     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037498     Document Type: Article

References (69)

1. Carbone A, Gloghini A, (2007) HHV-8-associated lymphoma: state-of-the-art review. Acta Haematol 117: 129-131.
2. Jenner RG, Maillard K, Cattini N, Weiss RA, Boshoff C, et al. (2003) Kaposi's sarcoma-associated herpesvirus-infected primary effusion lymphoma has a plasma cell gene expression profile. Proc Natl Acad Sci USA 100: 10399-10404.
3. Ganem D, (2006) KSHV infection and the pathogenesis of Kaposi's sarcoma. Annual Review of Pathology-Mechanisms of Disease 1: 273-296.
4. Chaudhary PM, Nicholas J, (2008) Molecular Biology of Human Herpesvirus 8 neoplasia. In: Nicholas J, Jeang KT, Wu TC, editors. Human Cancer Viruses Principles of Transformation and Pathogenesis Basel Karger pp. 186-210.
5. Dittmer D, Lagunoff M, Renne R, Staskus K, Haase A, et al. (1998) A cluster of latently expressed genes in Kaposi's sarcoma-associated herpesvirus. J Virol 72: 8309-8315.
6. Thome M, Schneider P, Hofmann K, Fickenscher H, Meinl E, et al. (1997) Viral FLICE-inhibitory proteins (FLIPs) prevent apoptosis induced by death receptors. Nature 386: 517-521.
7. Sun Q, Matta H, Chaudhary PM, (2003) The human herpes virus 8-encoded viral FLICE inhibitory protein protects against growth factor withdrawal-induced apoptosis via NF-kappa B activation. Blood 101: 1956-1961.
8. Sun Q, Zachariah S, Chaudhary PM, (2003) The human herpes virus 8-encoded viral FLICE-inhibitory protein induces cellular transformation via NF-kappaB activation. Journal of Biological Chemistry 278: 52437-52445.
9. Matta H, Chaudhary PM, (2004) Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta-converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci USA 101: 9399-9404.
10. Sun Q, Matta H, Lu G, Chaudhary PM, (2006) Induction of IL-8 expression by human herpesvirus 8 encoded vFLIP K13 via NF-kappaB activation. Oncogene 25: 2717-2726.
11. Chugh P, Matta H, Schamus S, Zachariah S, Kumar A, et al. (2005) Constitutive NF-kappaB activation, normal Fas-induced apoptosis, and increased incidence of lymphoma in human herpes virus 8 K13 transgenic mice. Proc Natl Acad Sci USA 102: 12885-12890.
12. Guasparri I, Keller SA, Cesarman E, (2004) KSHV vFLIP is essential for the survival of infected lymphoma cells. J Exp Med 199: 993-1003.
13. Matta H, Surabhi RM, Zhao J, Punj V, Sun Q, et al. (2007) Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8-encoded viral FLICE inhibitory protein K13. Oncogene 26: 1656-1660.
14. Xu Y, Ganem D, (2007) Induction of chemokine production by latent Kaposi's sarcoma-associated herpesvirus infection of endothelial cells. J Gen Virol 88: 46-50.
15. Grossmann C, Podgrabinska S, Skobe M, Ganem D, (2006) Activation of NF-kappaB by the latent vFLIP gene of Kaposi's sarcoma-associated herpesvirus is required for the spindle shape of virus-infected endothelial cells and contributes to their proinflammatory phenotype. J Virol 80: 7179-7185.
16. Lockhart DJ, Dong H, Byrne MC, Follettie MT, Gallo MV, et al. (1996) Expression monitoring by hybridization to high-density oligonucleotide arrays. Nat Biotechnol 14: 1675-1680.
17. Bild AH, Potti A, Nevins JR, (2006) Linking oncogenic pathways with therapeutic opportunities. Nat Rev Cancer 6: 735-741.
18. Vogelstein B, Kinzler KW, (2004) Cancer genes and the pathways they control. Nat Med 10: 789-799.
19. Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, et al. (2005) Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA 102: 15545-15550.
20. Crijns AP, Fehrmann RS, de Jong S, Gerbens F, Meersma GJ, et al. (2009) Survival-related profile, pathways, and transcription factors in ovarian cancer. PLoS Med 6: e24.
21. Matta H, Mazzacurati L, Schamus S, Yang T, Sun Q, et al. (2007) Kaposi's Sarcoma-associated Herpesvirus (KSHV) Oncoprotein K13 Bypasses TRAFs and Directly Interacts with the IkappaB Kinase Complex to Selectively Activate NF-kappaB without JNK Activation. J Biol Chem 282: 24858-24865.
22. Punj V, Matta H, Schamus S, Chaudhary PM, (2009) Integrated microarray and multiplex cytokine analyses of Kaposi's Sarcoma Associated Herpesvirus viral FLICE Inhibitory Protein K13 affected genes and cytokines in human blood vascular endothelial cells. BMC Med Genomics 2: 50.
23. Yang Y, Groshong JS, Matta H, Gopalakrishnan R, Yi H, et al. (2011) Constitutive NF-kappaB Activation Confers Interleukin 6 (IL6) Independence and Resistance to Dexamethasone and Janus Kinase Inhibitor INCB018424 in Murine Plasmacytoma Cells. J Biol Chem 286: 27988-27997.
24. Zhao J, Punj V, Matta H, Mazzacurati L, Schamus S, et al. (2007) K13 Blocks KSHV Lytic Replication and Deregulates vIL6 and hIL6 Expression: a Model of Lytic Replication Induced Clonal Selection in Viral Oncogenesis. PLoS ONE 2: e1067.
25. Matta H, Punj V, Schamus S, Mazzacurati L, Chen AM, et al. (2008) A nuclear role for Kaposi's sarcoma-associated herpesvirus-encoded K13 protein in gene regulation. Oncogene 27: 5243-5253.
26. Punj V, Matta H, Schamus S, Yang T, Chang Y, et al. (2009) Induction of CCL20 production by Kaposi sarcoma-associated herpesvirus: role of viral FLICE inhibitory protein K13-induced NF-kappaB activation. Blood 113: 5660-5668.
27. Chaudhary PM, Jasmin A, Eby MT, Hood L, (1999) Modulation of the NF-kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18: 5738-5746.
28. Matys V, Fricke E, Geffers R, Gossling E, Haubrock M, et al. (2003) TRANSFAC: transcriptional regulation, from patterns to profiles. Nucleic Acids Res 31: 374-378.
29. Sandelin A, Alkema W, Engstrom P, Wasserman WW, Lenhard B, (2004) JASPAR: an open-access database for eukaryotic transcription factor binding profiles. Nucleic Acids Res 32: D91-94.
30. Ho Sui SJ, Fulton DL, Arenillas DJ, Kwon AT, Wasserman WW, (2007) oPOSSUM: integrated tools for analysis of regulatory motif over-representation. Nucleic Acids Res 35: W245-252.
31. Vandesompele J, De Preter K, Pattyn F, Poppe B, Van Roy N, et al. (2002) Accurate normalization of real-time quantitative RT-PCR data by geometric averaging of multiple internal control genes. Genome Biol 3: RESEARCH0034.
32. Hellemans J, Mortier G, De Paepe A, Speleman F, Vandesompele J, (2007) qBase relative quantification framework and software for management and automated analysis of real-time quantitative PCR data. Genome Biol 8: R19.
33. Punj V, Matta H, Schamus S, Tamewitz A, Anyang B, et al. (2010) Kaposi's sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 suppresses CXCR4 expression by upregulating miR-146a. Oncogene 29: 1835-1844.
34. Sinha S, Adler AS, Field Y, Chang HY, Segal E, (2008) Systematic functional characterization of cis-regulatory motifs in human core promoters. Genome Res 18: 477-488.
35. Warner JB, Philippakis AA, Jaeger SA, He FS, Lin J, et al. (2008) Systematic identification of mammalian regulatory motifs' target genes and functions. Nat Methods 5: 347-353.
36. Roider HG, Kanhere A, Manke T, Vingron M, (2007) Predicting transcription factor affinities to DNA from a biophysical model. Bioinformatics 23: 134-141.
37. Hestand MS, van Galen M, Villerius MP, van Ommen GJ, den Dunnen JT, et al. (2008) CORE_TF: a user-friendly interface to identify evolutionary conserved transcription factor binding sites in sets of co-regulated genes. BMC Bioinformatics 9: 495.
38. Kim SY, Kim Y, (2006) Genome-wide prediction of transcriptional regulatory elements of human promoters using gene expression and promoter analysis data. BMC Bioinformatics 7: 330.
39. Matta H, Sun Q, Moses G, Chaudhary PM, (2003) Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory protein-induced NF-kappaB activation. Journal of Biological Chemistry 278: 52406-52411.
40. Appay V, Rowland-Jones SL, (2001) RANTES: a versatile and controversial chemokine. Trends Immunol 22: 83-87.
41. Baxter A, Brough S, Cooper A, Floettmann E, Foster S, et al. (2004) Hit-to-lead studies: the discovery of potent, orally active, thiophenecarboxamide IKK-2 inhibitors. Bioorg Med Chem Lett 14: 2817-2822.
42. Hideshima T, Chauhan D, Richardson P, Mitsiades C, Mitsiades N, et al. (2002) NF-kappa B as a therapeutic target in multiple myeloma. J Biol Chem 277: 16639-16647.
43. Nordan RP, Potter M, (1986) A macrophage-derived factor required by plasmacytomas for survival and proliferation in vitro. Science 233: 566-569.
44. Carbone A, Cesarman E, Spina M, Gloghini A, Schulz TF, (2009) HIV-associated lymphomas and gamma-herpesviruses. pp. 1213-1224.
45. Wen KW, Damania B, (2010) Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis. Cancer Lett 289: 140-150.
46. Keller SA, Schattner EJ, Cesarman E, (2000) Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells. Blood 96: 2537-2542.
47. Ahmad A, Groshong JS, Matta H, Schamus S, Punj V, et al. (2010) Kaposi's sarcoma associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 cooperates with Myc to promote lymphoma in mice. Cancer Biol Ther 10.
48. Ballon G, Chen K, Perez R, Tam W, Cesarman E, (2011) Kaposi sarcoma herpesvirus (KSHV) vFLIP oncoprotein induces B cell transdifferentiation and tumorigenesis in mice. J Clin Invest 121: 1141-1153.
49. Matta H, Gopalakrishnan R, Punj V, Yi H, Suo Y, et al. (2011) A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner. J Biol Chem 286: 21555-21564.
50. Aggarwal BB, (2004) Nuclear factor-kappaB: the enemy within. Cancer Cell 6: 203-208.
51. Hayden MS, Ghosh S, (2004) Signaling to NF-kappaB. Genes Dev 18: 2195-2224.
52. Karin M, Ben-Neriah Y, (2000) Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18: 621-663.
53. Liu L, Eby MT, Rathore N, Sinha SK, Kumar A, et al. (2002) The Human Herpes Virus 8-encoded Viral FLICE Inhibitory Protein Physically Associates with and Persistently Activates the Ikappa B Kinase Complex. J Biol Chem 277: 13745-13751.
54. Bonizzi G, Karin M, (2004) The two NF-kappaB activation pathways and their role in innate and adaptive immunity. Trends Immunol 25: 280-288.
55. Pomerantz JL, Baltimore D, (2002) Two pathways to NF-kappaB. Molecular Cell 10: 693-695.
56. Honma K, Tsuzuki S, Nakagawa M, Tagawa H, Nakamura S, et al. (2009) TNFAIP3/A20 functions as a novel tumor suppressor gene in several subtypes of non-Hodgkin lymphomas. Blood 114: 2467-2475.
57. Chiao PJ, Miyamoto S, Verma IM, (1994) Autoregulation of I kappa B alpha activity. Proc Natl Acad Sci USA 91: 28-32.
58. Yoshikawa H, Matsubara K, Qian GS, Jackson P, Groopman JD, et al. (2001) SOCS-1, a negative regulator of the JAK/STAT pathway, is silenced by methylation in human hepatocellular carcinoma and shows growth-suppression activity. Nat Genet 28: 29-35.
59. Crawford A, Angelosanto JM, Nadwodny KL, Blackburn SD, Wherry EJ, (2011) A role for the chemokine RANTES in regulating CD8 T cell responses during chronic viral infection. PLoS Pathog 7: e1002098.
60. Karnoub AE, Dash AB, Vo AP, Sullivan A, Brooks MW, et al. (2007) Mesenchymal stem cells within tumour stroma promote breast cancer metastasis. Nature 449: 557-563.
61. Suffee N, Richard B, Hlawaty H, Oudar O, Charnaux N, et al. (2011) Angiogenic properties of the chemokine RANTES/CCL5. Biochem Soc Trans 39: 1649-1653.
62. Tong H, Miyazaki Y, Yamazaki M, Hara H, Waldmann H, et al. (2010) Exacerbation of delayed-type hypersensitivity responses in EBV-induced gene-3 (EBI-3)-deficient mice. Immunol Lett 128: 108-115.
63. Collison LW, Chaturvedi V, Henderson AL, Giacomin PR, Guy C, et al. (2010) IL-35-mediated induction of a potent regulatory T cell population. Nat Immunol 11: 1093-1101.
64. Pan X, Cao H, Lu J, Shu X, Xiong X, et al. (2011) Interleukin-32 expression induced by hepatitis B virus protein X is mediated through activation of NF-kappaB. Mol Immunol 48: 1573-1577.
65. Smith AJ, Toledo CM, Wietgrefe SW, Duan L, Schacker TW, et al. (2011) The immunosuppressive role of IL-32 in lymphatic tissue during HIV-1 infection. J Immunol 186: 6576-6584.
66. Karin M, Lin A, (2002) NF-kappaB at the crossroads of life and death. Nat Immunol 3: 221-227.
67. Klein U, Gloghini A, Gaidano G, Chadburn A, Cesarman E, et al. (2003) Gene expression profile analysis of AIDS-related primary effusion lymphoma (PEL) suggests a plasmablastic derivation and identifies PEL-specific transcripts. Blood 101: 4115-4121.
68. Qi CF, Zhou JX, Lee CH, Naghashfar Z, Xiang S, et al. (2007) Anaplastic, plasmablastic, and plasmacytic plasmacytomas of mice: relationships to human plasma cell neoplasms and late-stage differentiation of normal B cells. Cancer Res 67: 2439-2447.
69. Hengge UR, Ruzicka T, Tyring SK, Stuschke M, Roggendorf M, et al. (2002) Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 2: pathogenesis, Castleman's disease, and pleural effusion lymphoma. Lancet Infect Dis 2: 344-352.